Table 1.
Studies included/ published, n |
Patients/ controls included, n |
|
---|---|---|
Neurological disorders | ||
Amyotrophic lateral sclerosis | 7/8 | 114/121 |
Dementia in Alzheimer's disease | 7/36 | 114/122 |
Dementia in Parkinson's | 7/10 | 133/172 |
Developmental dyslexia | 7/8 | 109/108 |
Dystonia | 7/10 | 151/160 |
Frontotemporal dementia | 7/37 | 158/170 |
Hereditary ataxia | 7/15 | 97/121 |
Huntington's disease | 7/9 | 206/165 |
Juvenile myoclonic epilepsy | 7/7 | 220/218 |
Multiple sclerosis | 7/11 | 335/179 |
Parkinson's disease | 7/17 | 216/197 |
Progressive supranuclear palsy | 7/7 | 108/182 |
Temporal lobe epilepsy – left | 7/14 | 232/334 |
Temporal lobe epilepsy – right | 7/10 | 196/246 |
Psychiatric disorders | ||
Attention-deficit hyperactivity disorder | 7/13 | 245/214 |
Anorexia nervosa | 7/10 | 108/130 |
Autism | 7/12 | 132/129 |
Asperger syndrome | 7/9 | 135/177 |
Bipolar affective disorder | 7/18 | 234/270 |
Depressive disorder | 7/24 | 146/205 |
Obsessive–compulsive disorder | 7/14 | 236/211 |
Panic disorder | 7/7 | 142/133 |
Post-traumatic stress disorder | 7/14 | 128/126 |
Schizophrenia | 7/51 | 332/414 |
For each disorder, we report the number of included and published studies and the total number of patients and healthy controls in the included studies. See Online supplement DS1 for details of the included studies.